<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5B52ED1A-B8F4-43BB-8CDC-9BC9163E93FA"><gtr:id>5B52ED1A-B8F4-43BB-8CDC-9BC9163E93FA</gtr:id><gtr:name>Moredun Research Institute</gtr:name><gtr:address><gtr:line1>PENTLANDS SCIENCE PARK , BUSH LOAN</gtr:line1><gtr:city>PENICUIK</gtr:city><gtr:postCode>EH26 0PZ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B52ED1A-B8F4-43BB-8CDC-9BC9163E93FA" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>5B52ED1A-B8F4-43BB-8CDC-9BC9163E93FA</gtr:id><gtr:name>Moredun Research Institute</gtr:name><gtr:address><gtr:line1>PENTLANDS SCIENCE PARK , BUSH LOAN</gtr:line1><gtr:city>PENICUIK</gtr:city><gtr:postCode>EH26 0PZ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>174749.0</gtr:offerGrant><gtr:projectCost>174749.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CC80B107-FC6F-4DD3-9074-0391C6B03714" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>CC80B107-FC6F-4DD3-9074-0391C6B03714</gtr:id><gtr:name>Benchmark Animal Health Limited</gtr:name><gtr:address><gtr:line1>BENCHMARK HOUSE , 8 SMITHY WOOD DRIVE</gtr:line1><gtr:city>SHEFFIELD</gtr:city><gtr:postCode>S35 1QN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>79858.0</gtr:offerGrant><gtr:projectCost>177462.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=132168"><gtr:id>FBF5CC5A-674A-4988-95BF-B2C37AB44B1A</gtr:id><gtr:title>Pan-specific vaccine to control Streptococcus agalactiae disease in tilapia aquaculture</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>132168</gtr:grantReference><gtr:abstractText>As the world population grows and becomes more affluent, an increasing number of people include

protein in their diet. Aquaculture is the fastest growing source of animal protein and a major source of

income in Asia, South-America and Africa. Tilapia is a popular fish, both with farmers and consumers,

but disease can cause massive losses on tilapia farms. Streptococcus agalactiae, which can affect tilapia

as well as people, is a major cause of such losses. Currently, antibiotics are commonly used to combat

this problem. This is not sustainable because of the risk of antimicrobial resistance. As an alternative, we

propose to develop a vaccine that would protect fish from all types of S. agalactiae that affect them. This

project brings together scientific expertise in the area of fish disease and vaccine development and

commercial expertise in vaccine production and distribution. Jointly, the partners aim to provide the

global aquaculture industry with effective and affordable tools for sustainable disease control.</gtr:abstractText><gtr:fund><gtr:end>2017-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>254607</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">132168</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>